An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis
Clinical trial NCT02518620 · COMPLETED
Trial details
- NCT number
- NCT02518620
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-08-01
- Enrollment
- 406
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.